These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2257351)

  • 1. Old BCG replaced by new vaccine? Human leukocyte antigens (HLA) and mycobacterial disease.
    de Vries R
    Bull Int Union Tuberc Lung Dis; 1990; 65(2-3):30-1. PubMed ID: 2257351
    [No Abstract]   [Full Text] [Related]  

  • 2. The immunological and epidemiological significance of environmental mycobacteria on leprosy and tuberculosis control.
    Pallen MJ
    Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):231-45. PubMed ID: 6427125
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccination and skin test studies on children living in villages with differing endemicity for leprosy and tuberculosis.
    Ghazi Saidi K; Stanford JL; Stanford CA; Dowlati Y; Farshchi Y; Rook GA; Rees RJ
    Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):45-53. PubMed ID: 2659701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunology of leprosy. New developments.
    Ottenhoff TH
    Trop Geogr Med; 1994; 46(2):72-80. PubMed ID: 8079394
    [No Abstract]   [Full Text] [Related]  

  • 5. Towards a vaccine against leprosy.
    Sengupta U
    Lepr India; 1981 Jan; 53(1):88-95. PubMed ID: 7012444
    [No Abstract]   [Full Text] [Related]  

  • 6. Under-explored experimental topics related to integral mycobacterial vaccines for leprosy.
    Gormus BJ; Meyers WM
    Expert Rev Vaccines; 2003 Dec; 2(6):791-804. PubMed ID: 14711362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cellular and molecular basis of immunity against mycobacterial diseases.
    Colston MJ
    Soc Appl Bacteriol Symp Ser; 1996; 25():33S-39S. PubMed ID: 8972118
    [No Abstract]   [Full Text] [Related]  

  • 8. The immunology of leprosy; unravelling an enigma.
    Choudhuri K
    Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):430-47. PubMed ID: 7594927
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycobacterium vaccae and immune responses: implications for leprosy control.
    Swinburne S; Brown IN; Brown CA
    Lepr Rev; 1985 Sep; 56(3):209-20. PubMed ID: 4058233
    [No Abstract]   [Full Text] [Related]  

  • 10. Prospects for new interventions in the treatment and prevention of mycobacterial disease.
    Young DB; Duncan K
    Annu Rev Microbiol; 1995; 49():641-73. PubMed ID: 8561475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategy for leprosy control.
    Lagrange PH; Stach JL
    Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):278-88. PubMed ID: 4020217
    [No Abstract]   [Full Text] [Related]  

  • 12. [The protective activity of mycobacterial antigens. 3. Protective activity of killed mycobacterial bodies].
    Stavri D; Anagnoste V; Drăghici D
    Arch Roum Pathol Exp Microbiol; 1970; 29(1):91-101. PubMed ID: 4936247
    [No Abstract]   [Full Text] [Related]  

  • 13. How environmental mycobacteria may predetermine the protective efficacy of BCG.
    Stanford JL; Shield MJ; Rook GA
    Tubercle; 1981 Mar; 62(1):55-62. PubMed ID: 7268920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant Mycobacterium bovis BCG.
    Bastos RG; Borsuk S; Seixas FK; Dellagostin OA
    Vaccine; 2009 Nov; 27(47):6495-503. PubMed ID: 19720367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Report on the effect of vaccination with BCG in the protection against mycobacterium infections].
    Rojas-Espinosa O
    Rev Latinoam Microbiol; 1976; 18(1):7-10. PubMed ID: 1070775
    [No Abstract]   [Full Text] [Related]  

  • 17. Mycobacterial proteins--immune targets for antituberculous subunit vaccine.
    Dhiman N; Khuller GK
    Indian J Exp Biol; 1999 Dec; 37(12):1157-66. PubMed ID: 10865880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of leprosy vaccine.
    Fine PE; Smith PG
    Nature; 1992 Dec; 360(6403):406. PubMed ID: 1448161
    [No Abstract]   [Full Text] [Related]  

  • 19. Limiting dilution analysis of the human T cell response to mycobacterial antigens from BCG vaccinated individuals and leprosy patients.
    Brett SJ; Kingston AE; Colston MJ
    Clin Exp Immunol; 1987 Jun; 68(3):510-20. PubMed ID: 3308217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The BCG controversy: a reappraisal of the protective effect against tuberculosis and leprosy.
    Zodpey SP
    Indian J Public Health; 2004; 48(2):70-7. PubMed ID: 15709589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.